Assembly Biosciences, Inc. (ASMB) has 20 已知的内部人和机构持有人记录. 最大持有人为 Zlotnick Adam 持有 1,321,009 股. 其他重要持有人包括 GILEAD SCIENCES, INC. 和 Small Derek A.
过去12个月，内部人进行了 16 笔交易，涉及 ASMB 股票 — 14 笔买入 (价值为 $25.19M) 和 2 笔卖出 (价值为 $687.25). 内部人买入超过卖出，可能表明对公司前景有信心.
ASMB 內部人持股
最大持股人
Zlotnick Adam
1,321,009 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Zlotnick Adam |
10 Percent Owner |
1,321,009 |
2014-09-09 |
|
| 2 |
Gilead Sciences, Inc. |
10 Percent Owner |
1,147,960 |
2025-10-03 |
|
| 3 |
Small Derek A |
Director |
828,791 |
2020-01-03 |
|
| 4 |
Schornstein Alexander |
10 Percent Owner |
720,137 |
2024-11-26 |
|
| 5 |
Ellison Russell H |
Director |
533,333 |
2015-04-15 |
|
| 6 |
Okazaki Jason A |
CEO and President |
111,916 |
2026-03-31 |
|
| 7 |
Samar Michael P. |
Chief Financial Officer |
77,228 |
2022-07-26 |
|
| 8 |
Russo Thomas Joseph |
CFO |
54,633 |
2021-04-02 |
|
| 9 |
Delaney William E Iv |
Chief Scientific Officer |
45,642 |
2026-03-31 |
|
| 10 |
White Nicole S |
Chief Manufacturing Officer |
37,674 |
2026-03-31 |
|
| 11 |
Papkoff Jacqueline Sybil |
SVP-CSO Microbiome |
37,364 |
2020-12-15 |
|
| 12 |
Cooper Graham K |
See Remarks |
35,000 |
2019-04-02 |
|
| 13 |
Colonno Richard James |
EVP & CSO, Virology Ops |
34,000 |
2020-03-31 |
|
| 14 |
Rowland Thomas Andrew |
Chief Business Officer |
30,000 |
2012-01-18 |
|
| 15 |
Gaggar Anuj |
Chief Medical Officer |
28,000 |
2026-03-31 |
|
| 16 |
Lopatin Uri A |
Chief Medical Officer |
27,500 |
2019-04-02 |
|
| 17 |
Barrett David Jonathan |
See Remarks |
25,000 |
2017-03-31 |
|
| 18 |
Stamm Luisa M |
Chief Medical Officer |
22,500 |
2022-03-31 |
|
| 19 |
Dimarchi Richard D |
Director |
20,000 |
2022-05-27 |
|
| 20 |
Holubiak Myron Z |
Director |
15,000 |
2021-05-24 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-29 |
Gaggar Anuj |
Chief Medical Officer |
限制性股票授予 (RSU) |
26,000 |
- |
- |
| 2026-03-30 |
White Nicole S |
Chief Manufacturing Officer |
知情卖出 |
9 |
$27.49 |
$247.41 |
| 2026-03-29 |
White Nicole S |
Chief Manufacturing Officer |
限制性股票授予 (RSU) |
26,000 |
- |
- |
| 2026-03-30 |
Bjorkquist Jeanette M |
Pfo and Pao |
知情卖出 |
16 |
$27.49 |
$439.84 |
| 2026-03-29 |
Bjorkquist Jeanette M |
Pfo and Pao |
限制性股票授予 (RSU) |
6,500 |
- |
- |
| 2026-03-29 |
Delaney William E Iv |
Chief Scientific Officer |
限制性股票授予 (RSU) |
26,000 |
- |
- |
| 2026-03-29 |
Okazaki Jason A |
CEO and President |
限制性股票授予 (RSU) |
94,250 |
- |
- |
| 2025-08-08 |
Gilead Sciences, Inc. |
10 Percent Owner |
知情买入 |
1,147,960 |
$21.60 |
$24.8M |
| 2025-06-16 |
Bjorkquist Jeanette M |
Pfo and Pao |
限制性股票授予 (RSU) |
600 |
$17.24 |
$10.34K |
| 2025-06-05 |
Houghton Michael |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
| 2025-06-05 |
Johnson-pratt Lisa |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
| 2025-06-05 |
Mchutchison John G |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
| 2025-06-05 |
Consylman Gina |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
| 2025-06-05 |
Mahony Susan |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
| 2025-06-05 |
Ringo William R |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
| 2025-06-05 |
Altig Anthony E |
Director |
限制性股票授予 (RSU) |
3,500 |
$15.81 |
$55.34K |
